- Original article
- Open Access
Value of hyperbaric oxygen therapy in the management of malignant otitis externa patients
The Egyptian Journal of Otolaryngology volume 31, pages143–148(2015)
Malignant external otitis is a rapidly spreading bacterial infection that is aggressive in nature and may be fatal if left untreated. Hyperbaric oxygen therapy (HBOT) is a medical treatment in which the entire body is placed in an airtight chamber at increased atmospheric pressure and has been proven to be effective for a number of different medical conditions.
The aim of this study was to assess the usefulness of HBOT as an adjunctive treatment in patients with malignant otitis externa.
Patients and methods
Forty-three diabetic patients, who had malignant otitis externa, underwent control of diabetes mellitus and were treated with ciprofloxacin. HBOT was administered to 15 patients as an adjunctive treatment. All the patients were evaluated clinically (in terms of ear discharge, granulations, and pain severity) and radiologically by a temporal bone computed tomography scan. The minimum follow-up duration in both groups was 2 months. HBOT was administered in one session every other day for 2 months, resulting in a total of 30 sessions. Patient factors analyzed included age, sex, ear discharge, and pain severity.
A total of 43 patients (28 men, 15 women) were divided into two groups: group A (28 patients) only received the antibiotic ciprofloxacin and group B (15 patients) was treated with ciprofloxacin and hyperbaric oxygen. The severity of pain improved considerably and the pain score decreased markedly from score 3 (severe) to score 0 (no pain) after 1 month in 46.7 and 93.3% of the patients by the end of the second month in comparison with patients treated only with the antibiotic: 0% after 1 month and 28.5% after 2 months. On clinical and microscopic examination, both ear discharge and granulations in the external canal had improved considerably. There was no ear discharge in 80% of patients in group B after one month treathent, 93.3% after 2 months, in comparison with 0% after 1 month, 28.5% after 2 months treatment in group A, highly statistically significant (P<0.001).
The addition of HBOT to medical treatment is highly effective and has facilitated considerable improvement in patients.
Karaman E, Yilmaz M, Ibrahimov M, Haciyev Y, Enver O. Malignant otitis externa. J Craniofac Surg 2012; 23: 1748–1751.
Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am 2008; 41: 537–549.
Kindwall E, Whelan H. Hyperbaric Medicine Practice. 2nd ed. Flagstaff, AZ: Best Publishing Company; 2004:chap 1, 18, 19, 20, 25, 29, 30.
Feldmeier J. Hyperbaric oxygen 2003: indications and results — The Hyperbaric Oxygen Therapy Committee Report. Kensington, Maryland: Undersea and Hyperbaric Medical Society Inc.; 2003.
Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 1990; 108: 847–850.
Davis JC, Gates GA, Lerner C, Davis MG Jr, Mader JT, Dinesman A. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 1992; 118: 89–93.
Kaide CG, Khandelwal S. Hyperbaric oxygen: applications in infectious disease. Emerg Med Clin North Am 2008; 26: 571–595.
Pilgramm M, Frey G, Schumann K. Hyperbaric oxygenation — a sensible adjunctive therapy in malignant external otitis. Laryngol Rhinol Otol (Stuttg) 1986; 65: 26–28.
Mader JT, Love JT. Malignant external otitis. Cure with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol 1982; 108: 38–40.
Gilain L, Labroue M, Aidan D, Ragu MP, Planquart X, Peynegre R. Value of hyperbaric oxygen therapy in the treatment of malignant otitis externa. Apropos of a case. Ann Otolaryngol Chir Cervicofac. 1993; 110: 50–54.
Tisch M, Lorenz KJ, Harm M, Lampl L, Maier H. The treatment of necrotizing otitis externa with a combination of surgery, antibiotics, specific immunoglobulins and hyperbaric oxygen therapy. Results of the Ulm Treatment Concept. HNO 2003; 51: 315–320.
Narozny W, Kuczkowski J, Stankiewicz C, Kot J, Mikaszewski B, Przewozny T. Value of hyperbaric oxygen in bacterial and fungal malignant external otitis treatment. Eur Arch Otorhinolaryngol 2006; 263: 680–684.
Shupak A, Greenberg E, Hardoff R, Gordon C, Melamed Y, Meyer WS. Hyperbaric oxygenation for necrotizing (malignant) otitis externa. Arch Otolaryngol Head Neck Surg 1989; 115: 1470–1475.
Heiden C. Malignant otitis externa: experience with hyperbaric oxygen therapy. Diving Hyperb Med 2010; 40: 182.
Saxby A, Barakate M, Kertesz T, James J, Bennett M. Malignant otitis externa: experience with hyperbaric oxygen therapy. Diving Hyperb Med 2010; 40: 195–200.
Sheikh AY, Gibson JJ, Rollins MD, Hopf HW, Hussain Z, Hunt TK. Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch Surg 2000; 135: 1293–1297.
Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic. The effect of inspired oxygen on infection. Arch Surg 1984; 119: 199–204.
Knighton DR, Fiegel VD, Halverson T, Schneider S, Brown T, Wells CL. Oxygen as an antibiotic. The effect of inspired oxygen on bacterial clearance. Arch Surg 1990; 125: 97–100.
Park MK, Myers RA, Marzella L. Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis 1992; 14: 720–740.
Phillips JS, Jones SEM. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa (Cochrane Review). In: The Cochrane Library, Issue 1, 2006. Oxford.
Conflicts of interest
About this article
Cite this article
Sabra, R.M., Taha, M.S., Khafagy, A.G. et al. Value of hyperbaric oxygen therapy in the management of malignant otitis externa patients. Egypt J Otolaryngol 31, 143–148 (2015). https://doi.org/10.4103/1012-5574.161598
- hyperbaric oxygen therapy
- otitis externa